H. Tian

Mapping the genetic landscape of suicide risk: Insights from genomic SEM.
20260 citationsauthor #7
Unique and overlapping mechanisms of valbenazine, deutetrabenazine, and vitamin E for tardive dyskinesia
20251 citationsauthor #9
Molecular targets of vortioxetine mediating glioblastoma suppression revealed by gene and protein network analyses and molecular docking simulations
20252 citationsauthor #10
Characterization of the Molecular Mechanisms Underlying Lurasidone‐Induced Acute Manic Episodes in Bipolar Depression: A Network Pharmacology and Molecular Docking Approach
20253 citationsauthor #9
Differentiations in Illness Duration, Thyroid-Stimulating Hormone, Glucose and P300 Latency Between Drug-Naïve Unipolar and Bipolar Depression: A Comparative Cross-Sectional Study
20251 citationsauthor #10
Aripiprazole alleviates the high prolactin levels induced by amisulpride via distinct molecular mechanisms: a network pharmacology and molecular docking study
20251 citationsauthor #5
Computational biological analysis reveals that HIF-1 and FoxO signaling pathways influence cognitive impairment in patients with depression
20250 citationsauthor #9
Exploring the potential antidepressant mechanisms of ibuprofen and celecoxib based on network pharmacology and molecular docking.
20250 citationsauthor #10
Exploring the Morphological Study of the Brain in Patients with Bipolar Disorder Based on Structural Magnetic Resonance Imaging
20250 citationsauthor #2
KarXT combines the partial benefits of haloperidol for positive symptoms and sulpiride for negative symptoms: Evidence from computational biology
20250 citationsauthor #9
Deciphering the Heterogeneity of Schizophrenia: A Multimodal and Multivariate Neuroimaging Framework for Unveiling Brain-Symptom Relationships and Underlying Subtypes.
20253 citationsauthor #18
Gray Matter Volume Abnormalities in Schizophrenia: Comparisons Between P-Value and Effect Size Inference Frameworks Using Mega- and Meta-Analyses.
20250 citationsauthor #17
Network pharmacology and molecular docking-based strategy to determine the potential mechanism for escitalopram-mediated long QT syndrome.
20252 citationsauthor #7
Shared and unique therapeutic targets of KarXT and clozapine for schizophrenia treatment revealed by network pharmacology and molecular docking analyses: Implications for differential clinical responses
20250 citationsauthor #3
Molecular mechanisms of quetiapine bidirectional regulation of bipolar depression and mania based on network pharmacology and molecular docking: Evidence from computational biology.
202412 citationsauthor #3
Selective disrupted gray matter volume covariance of amygdala subregions in schizophrenia
20241 citationsauthor #6
Exploring the potential pharmacological mechanism of aripiprazole against hyperprolactinemia based on network pharmacology and molecular docking
20247 citationsauthor #4
Modeling and 4E analysis of a new combined cooling, heating, and power energy system based on biogas combustion and hot oil for heat supply
202422 citationsauthor #1
Validity and reliability of a Chinese language suicide screening questionnaire-observer rating (CL-SSQ-OR) assessment for children/adolescents
20231 citationsauthor #2
Validity and reliability of a Chinese version of the Bergen Work Addiction Scale
20230 citationsauthor #2
Low-dose lithium adjunct to atypical antipsychotic treatment nearly improved cognitive impairment, deteriorated the gray-matter volume, and decreased the interleukin-6 level in drug-naive patients with first schizophrenia symptoms: a follow-up pilot study
20233 citationsauthor #6
Validation and reliability test of Chinese language patient-reported impact of symptoms in schizophrenia scale
20230 citationsauthor #2
Microglia and cognitive impairment in schizophrenia: translating scientific progress into novel therapeutic interventions
202334 citationsauthor #2
Validity and reliability of a Chinese version of the self‐evaluation of negative symptoms
20232 citationsauthor #3
Low-dose lithium adjunct to quetiapine improves cognitive task performance in mice with MK801-induced long-term cognitive impairment: Evidence from a pilot study.
20232 citationsauthor #2
Insulin Resistance/Diabetes and Schizophrenia: Potential Shared Genetic Factors and Implications for Better Management of Patients with Schizophrenia
202316 citationsauthor #8
Low-dose lithium mono- and adjunctive therapies improve MK-801-induced cognitive impairment and schizophrenia-like behavior in mice - Evidence from altered prefrontal lobe Ca2+ activity.
20235 citationsauthor #2
Validation of a modified Chinese‐language version of the Davos Assessment of Cognitive Biases Scale (MCL‐DACOBS) in a sample of Chinese patients with schizophrenia
20230 citationsauthor #3
Lithium produces bi-directionally regulation of mood disturbance, acts synergistically with anti-depressive/-manic agents, and did not deteriorate the cognitive impairment in murine model of bipolar disorder
20225 citationsauthor #3
Brain Neural Activity Patterns in an Animal Model of Antidepressant-Induced Manic Episodes
20221 citationsauthor #3
Transcranial direct current stimulation of the occipital lobes with adjunct lithium attenuates the progression of cognitive impairment in patients with first episode schizophrenia
20225 citationsauthor #2
Proposed protocol for the investigation of the safety and efficacy of the COVID-19 vaccine for patients with psychosis, with pilot safety findings from a Chinese psychiatrist's self-experiment.
20221 citationsauthor #18
Features of cognitive impairment and related risk factors in patients with major depressive disorder: A case-control study.
202213 citationsauthor #6
A borderline personality assessment for adolescents: Validity and reliability of the Chinese languages borderline personality features scale (short form version) for adolescents/children
20223 citationsauthor #8
Major depressive disorder comorbid with general anxiety disorder: Associations among neuroticism, adult stress, and the inflammatory index.
202232 citationsauthor #9
Lithium bidirectionally regulates depression- and mania-related brain functional alterations without worsening cognitive function in patients with bipolar disorder
20221 citationsauthor #4
In the era of whole-brain mapping for the exploration of mental disorders, we need to rethink our methods of rodent model establishment
20221 citationsauthor #2
Prevalence of Heavy Menstrual Bleeding and Its Associated Cognitive Risks and Predictive Factors in Women With Severe Mental Disorders
20222 citationsauthor #2
Childhood adversity, adulthood adversity and suicidal ideation in Chinese patients with major depressive disorder: in line with stress sensitization
202212 citationsauthor #9
Risk-to-befit ratios of consecutive antidepressants for heavy menstrual bleeding in young women with bipolar disorder or major depressive disorder
20222 citationsauthor #14
Mechanistic/mammalian target of rapamycin and side effects of antipsychotics: insights into mechanisms and implications for therapy
202219 citationsauthor #11
Acid sphingomyelinase/ceramide system in schizophrenia: implications for therapeutic intervention as a potential novel target
202225 citationsauthor #3
Metabolic risk factors of cognitive impairment in young women with major psychiatric disorder
20226 citationsauthor #22
Morphometric Integrated Classification Index: A Multisite Model-Based, Interpretable, Shareable and Evolvable Biomarker for Schizophrenia.
20227 citationsauthor #10
Baseline global brain structural and functional alterations at the time of symptom onset can predict subsequent cognitive deterioration in drug-naïve first-episode schizophrenia patients: Evidence from a follow-up study
20222 citationsauthor #11
Testing the validity and reliability of the Chinese version of the Staden schizophrenia anxiety rating scale
20227 citationsauthor #10
OGDHL Variant rs2293239: A Potential Genetic Driver of Chinese Familial Depressive Disorder
20224 citationsauthor #2
Associations of cognitive impairment in patients with schizophrenia with genetic features and with schizophrenia-related structural and functional brain changes
20225 citationsauthor #2
Higher benefit-risk ratio of COVID-19 vaccination in patients with schizophrenia and major depressive disorder versus patients with bipolar disorder when compared to controls.
20223 citationsauthor #2
Electrical stimulus combined with venlafaxine and mirtazapine improves brain Ca2+ activity, pre-pulse inhibition, and immobility time in a model of major depressive disorder in schizophrenia.
20224 citationsauthor #9
Exploring neurometabolic alterations in bipolar disorder with suicidal ideation based on proton magnetic resonance spectroscopy and machine learning technology
202211 citationsauthor #8
Effects of CYP2D6, CYP3A5, and ABCB1 gene polymorphisms on the pharmacokinetics of two risperidone long-acting injection microsphere formulations.
20213 citationsauthor #13
The effect of selective serotonin reuptake inhibitors on cognitive impairment in patients with depression: A prospective, multicenter, observational study.
202119 citationsauthor #6
Machine learning to predict clinical remission in depressed patients after acute phase selective serotonin reuptake inhibitor treatment.
202113 citationsauthor #5
Neurocognitive profiles of patients with first-episode and recurrent depression: a cross-sectional comparative study from China.
202113 citationsauthor #9
Comparative Cardio-Renal Outcomes of Type 2 Diabetes Patients Administered Glucagon-Like Peptide-1 Receptor Agonists: A Network Meta-Analysis
20213 citationsauthor #7
Safety and Efficacy of High-Dose Vitamin B6 as an Adjunctive Treatment for Antipsychotic-Induced Hyperprolactinemia in Male Patients With Treatment-Resistant Schizophrenia
20219 citationsauthor #15
Differential effects of alcohol‐drinking patterns on the structure and function of the brain and cognitive performance in young adult drinkers: A pilot study
20217 citationsauthor #11
Severe sleep disturbance is associated with executive function impairment in patients with first-episode, treatment-naïve major depressive disorders
20217 citationsauthor #5
Left Cerebral Cortex Complexity in Patients with Major Depression Disorder: A Small-Sample Pilot Study
20212 citationsauthor #8
Irreversible Primary Visual Cortex Impairment in a Mouse Model of High-Risk Schizophrenia
20210 citationsauthor #11
Unstructured Group Support Enhances Compliance to Pharmacological Treatment by Improving Social Cognition in Patients with Bipolar Disorder: A Pilot fMRI Study
20211 citationsauthor #3
Inflammatory cytokines, cognition, and response to antidepressant treatment in patients with major depressive disorder.
202115 citationsauthor #5
Irreversible Primary Visual Cortex Impairment in a Mouse Model of High-Risk Schizophrenia
20214 citationsauthor #10
Antipsychotics With Different Chemical Structures Cause Different Degrees of Functional Impairments in the Primary Visual Cortex in a Murine Model: A Pilot Study
20210 citationsauthor #10
Calcium imaging reveals depressive- and manic-phase-specific brain neural activity patterns in a murine model of bipolar disorder: a pilot study
20215 citationsauthor #2
Clozapine induces metformin-resistant prediabetes/diabetes that is associated with poor clinical efficacy in patients with early treatment-resistant schizophrenia.
202116 citationsauthor #8
Ketamine plus propofol-electroconvulsive therapy (ECT) transiently improves the antidepressant effects and the associated brain functional alterations in patients with propofol-ECT-resistant depression.
202012 citationsauthor #2
Disrupted pathways from frontal-parietal cortex to basal ganglia and cerebellum in patients with unmedicated obsessive compulsive disorder as observed by whole-brain resting-state effective connectivity analysis – a small sample pilot study
202013 citationsauthor #6
Patients with first-episode untreated schizophrenia who experience concomitant visual disturbances and auditory hallucinations exhibit co-impairment of the brain and retinas—a pilot study
202015 citationsauthor #6
Supportive Family Environments can Improve Treatment Compliance, Social Cognition, Brain Activity in Patients with Schizophrenia - A Pilot Study
20201 citationsauthor #6
Neural mechanisms underlying visual and auditory processing impairments in schizophrenia: insight into the etiology and implications for tailoring preventive and therapeutic interventions.
202010 citationsauthor #2
Left cerebral cortex complexity differences in sporadic healthy individuals with auditory verbal hallucinations: A pilot study.
20206 citationsauthor #7
Exploration of the cortical pathophysiology underlying visual disturbances in schizophrenia comorbid with depressive disorder—An evidence from mouse model
20202 citationsauthor #8
Common and distinct brain functional alterations in pharmacotherapy treatment-naïve female borderline personality disorder patients with and without auditory verbal hallucinations: a pilot study
202010 citationsauthor #4
Association between ErbB4 gene function in synaptogenesis and schizophrenia pathogenesis
20201 citationsauthor #3
Strategies to solve the reverse inference fallacy in future MRI studies of schizophrenia: a review
20200 citationsauthor #6
Adjunct ketamine treatment of depression in treatment‐resistant schizophrenia patients is unsatisfactory in pilot and secondary follow‐up studies
20206 citationsauthor #3
Brain features of nearly drug‐naïve female monozygotic twins with first‐episode schizophrenia and the classification accuracy of brain feature patterns: A pilot study
20202 citationsauthor #9
Common and distinct global functional connectivity density alterations in drug-naïve patients with first-episode major depressive disorder with and without auditory verbal hallucination.
202014 citationsauthor #4
Depression and cardiovascular disease: Shared molecular mechanisms and clinical implications.
2020114 citationsauthor #4
Metformin Enhances Antidepressant/Antipsychotic Combination Therapy of Schizophrenia With Comorbid Depression in a Murine Model
202012 citationsauthor #8
Associations among serum markers of inflammation, life stress and suicide risk in patients with major depressive disorder.
202017 citationsauthor #9
Rethinking Schizophrenia and Depression Comorbidity as One Psychiatric Disorder Entity: Evidence From Mouse Model
202015 citationsauthor #9
Transient effects of multi‐infusion ketamine augmentation on treatment‐resistant depressive symptoms in patients with treatment‐resistant bipolar depression – An open‐label three‐week pilot study
202032 citationsauthor #3
Global functional connectivity density alterations in patients with bipolar disorder with auditory verbal hallucinations and modest short‐term effects of transcranial direct current stimulation augmentation treatment—Baseline and follow‐up study
20207 citationsauthor #4
Differences in functional connectivity density among subtypes of schizophrenic auditory hallucination
202010 citationsauthor #8
Mortality risk following acute coronary syndrome among patients with schizophrenia: A meta-analysis.
202014 citationsauthor #2
Unified and disease specific alterations to brain structure in patients across six categories of mental disorders who experience own-thought auditory verbal hallucinations: A pilot study.
20206 citationsauthor #8
Brain imaging features in schizophrenia with co‐occurring auditory verbal hallucinations and depressive symptoms—Implication for novel therapeutic strategies to alleviate the reciprocal deterioration
202012 citationsauthor #8
Depression predicts the risk of adverse events after percutaneous coronary intervention: A meta-analysis.
202025 citationsauthor #6
Reduced rate of revascularization in schizophrenic patients with acute myocardial infarction: A systematic review and meta-analysis.
202010 citationsauthor #6
Comparative safety of glucagon like peptide‑1 receptor agonists in patients with type 2 diabetes: a network meta-analysis of cardiovascular outcome trials
20200 citationsauthor #2
Sleep Disturbance Severity is Associated With Cognitive Impairment in Patients With First-episode, Treatment-naïve Major Depressive Disorders
20200 citationsauthor #5
Lipidomics of the brain, retina, and biofluids: from the biological landscape to potential clinical application in schizophrenia
202023 citationsauthor #3
Maintenance Repetitive Transcranial Magnetic Stimulation (rTMS) Weakly Improved Treatment Effect in Patients with Treatment-Resistant Schizophrenia Who Responded to maintenance ECT and Adjunct Olanzapine Treatment - A Pilot Study
20202 citationsauthor #5
Mental health stigma and mental health knowledge in Chinese population: a cross-sectional study
2020154 citationsauthor #4
Strategies to solve the reverse inference fallacy in future MRI studies of schizophrenia: a review
20208 citationsauthor #6
Reliability and Diagnostic Validity of a Novel Visual Disturbance Subjective Experience Scale in Chinese Patients with Schizophrenia
20204 citationsauthor #6
Disrupted pathways from the frontal-parietal cortices to basal nuclei and the cerebellum are a feature of the obsessive-compulsive disorder spectrum and can be used to aid in early differential diagnosis.
20205 citationsauthor #9

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT